Phase Ii evaluation of vindesine in patients with advanced breast cancer
Currie, V.E.; Camacho, F.; Wittes, R.; Young, C.
Cancer Treatment Reports 64(4-5): 693-695
1980
ISSN/ISBN: 0361-5960 PMID: 7427954 Document Number: 162792
Document emailed within 1 workday
Related Documents
Kenny, J.B.; Scarffe, J.H.; Maley, W.V. 1983: Phase Ii trial of vindesine in advanced gastric cancer Cancer Treatment Reports 67(1): 89-90Vogl, S.E.; Camacho, F.J.; Kaplan, B.H.; O'Donnell, M.R. 1984: Phase Ii trial of vindesine in advanced squamous cell cancer of the head and neck Cancer Treatment Reports 68(3): 559-560
Taguchi, T.; Mori, S.; Abe, R.; Hasegawa, K.; Morishita, Y.; Tabei, T.; Sasaki, Y.; Fujita, M.; Enomoto, K.; Hamano, K. 1994: Late phase Ii clinical study of RP56976 (docetaxel) in patients with advanced/recurrent breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(15): 2625-2632
Creagan, E.T.; Nichols, W.C.; O'Fallon, J.R. 1981: Phase Ii evaluation of PALA in patients with advanced head and neck cancer Cancer Treatment Reports 65(9-10): 827-829
Nichols, W.C.; Kvols, L.K.; Ingle, J.N.; Edmonson, J.H.; Ahmann, D.L.; Rubin, J.; O'Connell, M.J. 1978: Phase Ii study of triazinate and pyrazofurin in patients with advanced breast cancer previously exposed to cytotoxic chemotherapy Cancer Treatment Reports 62(5): 837-839
Kris, M.G.; Kinahan, J.J.; Gralla, R.J.; Fanucchi, M.P.; Wertheim, M.S.; O'Connell, J.P.; Marks, L.D.; Williams, L.; Farag, F.; Young, C.W. 1988: Phase i trial and clinical pharmacological evaluation of 10-ethyl-10-deazaaminopterin in adult patients with advanced cancer Cancer Research 48(19): 5573-5579
Cosmas, C.; Tsavaris, N.; Malamos, N.; Tsakonas, G.; Gassiamis, A.; Skopelitis, H.; Soukouli, G.; Polyzos, A.; Mylonakis, N.; Karabelis, A. 2005: Dose escalation of docetaxel and ifosfamide in patients with advanced breast cancer failing prior anthracyclines: mature results of a phase I-Ii study Journal of Buon: Official Journal of the Balkan Union of Oncology 10(3): 337-346
Muthalib, A.; Darwis, I.; Prayogo, N.; Sutjipto 2000: Preliminary results of multicenter phase Ii trial of docetaxel (Taxotere) in combination with doxorubicin as first line chemotherapy in Indonesian patients with advanced or metastatic breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(Suppl 2): 498-504
Chang, A.Y.; Witte, R.S.; Tormey, D.C.; Ramirez, G. 1984: Evaluation of vindesine in patients with refractory small cell lung cancer Cancer Treatment Reports 68(11): 1407-1408
Edmonson, J.H.; Rubin, J.; Kvols, L.K.; O'Connell, M.J.; Frytak, S.; Green, S.J. 1981: Phase II study of maytansine in advanced breast cancer Cancer Treatment Reports 65(5-6): 536-537
Ogawa, M.; Kubo, K.; Tominaga, T.; Nomura, Y.; Ota, K.; Yoshida, M.; Taguchi, T.; Hoshino, A. 1986: Phase Ii study of mitoxantrone in advanced breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(5): 1980-1984
Rouësse, J.G.; Le Chevalier, T.; Caille, P.; Mondesir, J.M.; Sancho-Garnier, H.; May-Levin, F.; Spielmann, M.; De Jager, R.; Amiel, J.L. 1985: Phase Ii study of elliptinium in advanced breast cancer Cancer Treatment Reports 69(6): 707-708
Yap, H.Y.; Salem, P.; Hortobagyi, G.N.; Bodey, G.P.; Buzdar, A.U.; Tashima, C.K.; Blumenschein, G.R. 1978: Phase Ii study of cis-dichlorodiammineplatinum(II) in advanced breast cancer Cancer Treatment Reports 62(3): 405-408
Lionetto, R.; Pronzato, P.; Conte, P.F.; Sertoli, M.R.; Amoroso, D.; Rosso, R. 1986: Idarubicin in advanced breast cancer: a phase II study Cancer Treatment Reports 70(12): 1439-1440
Amadori, D.; Frassineti, G.L.; Zoli, W.; Tienghi, A.; Ravaioli, A.; Casadei Giunchi, D.; Gentile, A.; Salzano, E. 1996: A Phase I/Ii study of paclitaxel and doxorubicin in the treatment of advanced breast cancer Seminars in Oncology 23(1 Suppl 1: 19-23
Wada, Y.; Otoshi, M.; Jitsuko, A.; Nishikawa, H.; Takahara, S.; Tsubono, M.; Imai, S. 2007: A phase Ii study of weekly paclitaxel for advanced or recurrent breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 34(7): 1041-1045
Tominaga, T.; Nomura, Y.; Adachi, I.; Aoyama, H.; Nagao, K.; Mitsuyama, S.; Nakamura, Y.; Ogita, M.; Sano, M.; Takashima, S. 1994: Late phase II study of KW-2307 in advanced or recurrent breast cancer. KW-2307 Cooperative Study Group (Breast Cancer Section) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(6): 809-816
Pedrazzoli, P.; Zamagni, C.; Martoni, A.; Capotorto, A.M.; Da Prada, G.A.; Pavesi, L.; Preti, P.; Lelli, G.; Pannuti, F.; Robustelli della Cuna, G. 1994: Dose intensification of chemotherapy in advanced breast cancer: a feasibility phase II study Tumori 80(4): 273-275
Dieras, V.; Marty, M.; Tubiana, N.; Corette, L.; Morvan, F.; Serin, D.; Mignot, L.; Chazard, M.; Garet, F.; Onetto, N. 1995: Phase Ii randomized study of paclitaxel versus mitomycin in advanced breast cancer Seminars in Oncology 22(4 Suppl 8: 33-39
Stamatovic, L.; Susnjar, S.; Gavrilovic, D.; Minic, I.; Ursulovic, T.; Dzodic, R. 2018: The influence of breast cancer subtypes on the response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer patients Journal of Buon: Official Journal of the Balkan Union of Oncology 23(5): 1273-1280